Protein-protein interaction ( PPI ) network and significant gene analysis of breast cancer
暂无分享,去创建一个
Weihua Ren | Yawei Li | Shuangting Wu | Hongbo Feng | Rui Li | Weihua Ren | Shuangting Wu | Rui Li | Hongbo Feng | Ya-wei Li
[1] Jorge S Reis-Filho,et al. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade , 2010, The Journal of pathology.
[2] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[3] G. Enders. Expanded Roles for Chk1 in Genome Maintenance* , 2008, Journal of Biological Chemistry.
[4] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[5] S. Weroha,et al. Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth , 2013, Molecular Cancer Therapeutics.
[6] Dong Ryul Lee,et al. The Novel miR-7515 Decreases the Proliferation and Migration of Human Lung Cancer Cells by Targeting c-Met , 2012, Molecular Cancer Research.
[7] B. Zhu,et al. Role of Cyclin B1/Cdc2 Up-Regulation in the Development of Mitotic Prometaphase Arrest in Human Breast Cancer Cells Treated with Nocodazole , 2011, PloS one.
[8] M. Baggiolini,et al. Interleukin-8 and the chemokine family. , 1995, International journal of immunopharmacology.
[9] F. Grosse,et al. Human Cdc45 is a proliferation‐associated antigen , 2007, The FEBS journal.
[10] Richard D Kolodner,et al. An overview of Cdk1-controlled targets and processes , 2010, Cell Division.
[11] T. Yeatman,et al. Novel Molecular Markers of Malignancy in Histologically Normal and Benign Breast , 2011, Pathology research international.
[12] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[13] Randall Harris. Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. , 2007, Sub-cellular biochemistry.
[14] M. Frommer,et al. Role of radiotherapy in cancer control in low-income and middle-income countries. , 2006, The Lancet. Oncology.
[15] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[16] K L Gould,et al. Regulating the onset of mitosis. , 1999, Current opinion in cell biology.
[17] Anthony Howell. The emerging breast cancer epidemic: early diagnosis and treatment , 2010, Breast Cancer Research.
[18] M. Martinka,et al. Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers , 2006, Clinical Cancer Research.
[19] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[20] Mitch Dowsett,et al. Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer , 2008, Clinical Cancer Research.
[21] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[22] M. Burdick,et al. Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.
[23] F. Cross,et al. Regulated degradation of the APC coactivator Cdc20 , 2010, Cell Division.
[24] Qing Yang,et al. Screening of feature genes of the ovarian cancer epithelia with DNA microarray , 2013, Journal of Ovarian Research.
[25] Michael Kohl,et al. Cytoscape: software for visualization and analysis of biological networks. , 2011, Methods in molecular biology.
[26] T. Halazonetis,et al. Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.
[27] Kahn Rhrissorrakrai,et al. MINE: Module Identification in Networks , 2011, BMC Bioinformatics.
[28] Ying Lin,et al. Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells , 2007, International journal of cancer.
[29] T. Tan,et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients , 2014, EMBO molecular medicine.
[30] C. Shriver,et al. Molecular response of the axillary lymph node microenvironment to metastatic colonization , 2014, Clinical & Experimental Metastasis.
[31] Haiyang Xie,et al. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis , 2015, Journal of Experimental & Clinical Cancer Research.
[32] Xinguo Jiang,et al. The immune system and inflammation in breast cancer , 2014, Molecular and Cellular Endocrinology.
[33] Yue Xiong,et al. p15PAF, a novel PCNA associated factor with increased expression in tumor tissues , 2001, Oncogene.
[34] F. Jänicke,et al. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma , 2008, British Journal of Cancer.
[35] R. Sinha,et al. Opportunities for cancer epidemiology in developing countries , 2004, Nature Reviews Cancer.
[36] T. Poggio,et al. Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] Byong Hoon Yoo,et al. Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties , 2013, Hormones and Cancer.
[38] B. Casto,et al. Cyclooxygenase-2 and the inflammogenesis of breast cancer. , 2014, World journal of clinical oncology.
[39] P. Hoff,et al. Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib , 2014, British Journal of Cancer.
[40] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[41] Jiri Bartek,et al. An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.
[42] J. Li,et al. Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State , 2014, Molecular and Cellular Biology.
[43] J. Julian Blow,et al. Replication licensing and cancer — a fatal entanglement? , 2008, Nature Reviews Cancer.
[44] M. Zabel,et al. COX-2 expression pattern is related to ovarian cancer differentiation and prognosis, but is not consistent with new model of pathogenesis. , 2014, Ginekologia polska.
[45] M. Blaser,et al. Mechanisms of Disease: inflammation and the origins of cancer , 2005, Nature Clinical Practice Oncology.
[46] Aristides G. Eliopoulos,et al. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins , 2011, The Journal of cell biology.
[47] Tsung-Hsien Chang,et al. Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions , 2014, PloS one.